Stephen Gucker

Array ( [id] => 3622930 [patent_doc_number] => 05602096 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-02-11 [patent_title] => 'Method of using a secretable glial mitogenic factor to induce acetylcholine receptor synthesis' [patent_app_type] => 1 [patent_app_number] => 8/472008 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 78 [patent_figures_cnt] => 89 [patent_no_of_words] => 35579 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/602/05602096.pdf [firstpage_image] =>[orig_patent_app_number] => 472008 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 958723 [patent_doc_number] => 06953668 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2005-10-11 [patent_title] => 'Prostate-specific membrane antigen' [patent_app_type] => utility [patent_app_number] => 08/466381 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 48 [patent_figures_cnt] => 60 [patent_no_of_words] => 24052 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/953/06953668.pdf [firstpage_image] =>[orig_patent_app_number] => 08466381 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 408213 [patent_doc_number] => 07285531 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2007-10-23 [patent_title] => 'Method for prophylaxis or treatment of a nervous system, pathophysiological condition involving a glial growth factor sensitive cell by administration of a glial growth factor' [patent_app_type] => utility [patent_app_number] => 08/472065 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 78 [patent_figures_cnt] => 88 [patent_no_of_words] => 28039 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 56 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/285/07285531.pdf [firstpage_image] =>[orig_patent_app_number] => 08472065 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4355847 [patent_doc_number] => 06190880 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-02-20 [patent_title] => 'Recombinant bone morphogenetic protein heterodimers, compositions and methods of use' [patent_app_type] => 1 [patent_app_number] => 8/469411 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 34 [patent_figures_cnt] => 14 [patent_no_of_words] => 19519 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/190/06190880.pdf [firstpage_image] =>[orig_patent_app_number] => 469411 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 657591 [patent_doc_number] => 07105159 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2006-09-12 [patent_title] => 'Antibodies to prostate-specific membrane antigen' [patent_app_type] => utility [patent_app_number] => 08/470735 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 48 [patent_figures_cnt] => 60 [patent_no_of_words] => 24008 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/105/07105159.pdf [firstpage_image] =>[orig_patent_app_number] => 08470735 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4403486 [patent_doc_number] => 06270998 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-08-07 [patent_title] => 'DNA coding for human cell surface antigen' [patent_app_type] => 1 [patent_app_number] => 8/468560 [patent_app_country] => US [patent_app_date] => 1995-06-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 18 [patent_no_of_words] => 13891 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/270/06270998.pdf [firstpage_image] =>[orig_patent_app_number] => 468560 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3787142 [patent_doc_number] => 05840689 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-11-24 [patent_title] => 'Method for stimulating the regrowth of neurons' [patent_app_type] => 1 [patent_app_number] => 8/458555 [patent_app_country] => US [patent_app_date] => 1995-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 7 [patent_no_of_words] => 5204 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 134 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/840/05840689.pdf [firstpage_image] =>[orig_patent_app_number] => 458555 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4149220 [patent_doc_number] => 06103243 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-08-15 [patent_title] => 'Oral vaccines' [patent_app_type] => 1 [patent_app_number] => 8/458814 [patent_app_country] => US [patent_app_date] => 1995-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 14128 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 99 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/103/06103243.pdf [firstpage_image] =>[orig_patent_app_number] => 458814 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3989063 [patent_doc_number] => 05891652 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-04-06 [patent_title] => 'Methods of using domains of extracellular region of human platelet-derived growth factor receptor polypeptides' [patent_app_type] => 1 [patent_app_number] => 8/460490 [patent_app_country] => US [patent_app_date] => 1995-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 4 [patent_no_of_words] => 21400 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 145 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/891/05891652.pdf [firstpage_image] =>[orig_patent_app_number] => 460490 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4412138 [patent_doc_number] => 06229000 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-05-08 [patent_title] => 'Tissue-specific human neuronal calcium channel subtypes and their use' [patent_app_type] => 1 [patent_app_number] => 8/456200 [patent_app_country] => US [patent_app_date] => 1995-05-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4019 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/229/06229000.pdf [firstpage_image] =>[orig_patent_app_number] => 456200 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4133869 [patent_doc_number] => 06015572 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-01-18 [patent_title] => 'Implantable device containing GDNF secreting cells for treating nerve damage and methods of use' [patent_app_type] => 1 [patent_app_number] => 8/453176 [patent_app_country] => US [patent_app_date] => 1995-05-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 36 [patent_no_of_words] => 30439 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/015/06015572.pdf [firstpage_image] =>[orig_patent_app_number] => 453176 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3725898 [patent_doc_number] => 05702906 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-12-30 [patent_title] => 'Antibodies to neurotrophic factor-4 (NT-4)' [patent_app_type] => 1 [patent_app_number] => 8/451947 [patent_app_country] => US [patent_app_date] => 1995-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 18818 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/702/05702906.pdf [firstpage_image] =>[orig_patent_app_number] => 451947 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3858203 [patent_doc_number] => 05792656 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-08-11 [patent_title] => 'Methods of preparing genetically engineered cells that produce insulin in response to glucose' [patent_app_type] => 1 [patent_app_number] => 8/452346 [patent_app_country] => US [patent_app_date] => 1995-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 17 [patent_no_of_words] => 23389 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 73 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/792/05792656.pdf [firstpage_image] =>[orig_patent_app_number] => 452346 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3795273 [patent_doc_number] => 05780600 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-07-14 [patent_title] => 'Purified ciliary neurotrophic factor' [patent_app_type] => 1 [patent_app_number] => 8/448909 [patent_app_country] => US [patent_app_date] => 1995-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 24 [patent_no_of_words] => 20708 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/780/05780600.pdf [firstpage_image] =>[orig_patent_app_number] => 448909 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3660896 [patent_doc_number] => 05648334 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-07-15 [patent_title] => 'Methods of treatment using ciliary neurotrophic factor' [patent_app_type] => 1 [patent_app_number] => 8/449329 [patent_app_country] => US [patent_app_date] => 1995-05-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 19 [patent_no_of_words] => 20936 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 39 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/648/05648334.pdf [firstpage_image] =>[orig_patent_app_number] => 449329 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3769777 [patent_doc_number] => 05733875 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-03-31 [patent_title] => 'Methods of using GDNF as a neuroprotective agent' [patent_app_type] => 1 [patent_app_number] => 8/446383 [patent_app_country] => US [patent_app_date] => 1995-05-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 7 [patent_no_of_words] => 6752 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 92 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/733/05733875.pdf [firstpage_image] =>[orig_patent_app_number] => 446383 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 3738896 [patent_doc_number] => 05753521 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-05-19 [patent_title] => 'Molecular cloning of genomic and CDNA sequences encoding cellular receptors for poliovirus' [patent_app_type] => 1 [patent_app_number] => 8/446049 [patent_app_country] => US [patent_app_date] => 1995-05-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 17 [patent_no_of_words] => 12638 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/753/05753521.pdf [firstpage_image] =>[orig_patent_app_number] => 446049 [rel_patent_id] =>[rel_patent_doc_number] =>)